Zimmer Biomet Holdings Inc

Zimmer Biomet insider buying: Noor Jehanzeb’s RSU and stock purchases signal executive confidence amid a 27.8% drop, hinting at potential upside for long‑term investors.

Zimmer Biomet insiders are buying phantom stock—Jafry Syed’s latest purchase signals bullish confidence and could boost the stock as the company’s growth strategy matures.

Zimmer Biomet CFO’s latest buy‑sell trade shows steady insider confidence and disciplined equity management, reinforcing long‑term growth potential.

Insider buying at Zimmer Biomet shows long‑term confidence: Noor Jehanzeb’s 10k RSU purchase signals bullish outlook and potential growth in bone‑growth stimulation, plus a fresh dividend boost for investors.